Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Invested Capital: 2009-2024

Historic Invested Capital for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $7.6 billion.

  • Fresenius Medical Care AG's Invested Capital rose 1136.25% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year decrease of 7196.6%. This contributed to the annual value of $32.5 billion for FY2024, which is 14.33% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Invested Capital stood at $7.6 billion for Q3 2025, which was up 1136.25% from $7.9 billion recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Invested Capital peaked at $24.4 billion during Q4 2021, and registered a low of -$6.9 billion during Q3 2021.
  • Its 5-year average for Invested Capital is $9.7 billion, with a median of $7.1 billion in 2023.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Invested Capital plummeted by 18595.61% in 2021, and later surged by 19663.93% in 2022.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Invested Capital stood at $24.4 billion in 2021, then fell by 8.63% to $22.3 billion in 2022, then grew by 0.54% to $22.4 billion in 2023, then rose by 4.02% to $23.3 billion in 2024, then tumbled by 67.35% to $7.6 billion in 2025.
  • Its Invested Capital stands at $7.6 billion for Q3 2025, versus $7.9 billion for Q2 2025 and $6.6 billion for Q1 2025.